1 |
Giordano TJ. Genomic hallmarks of thyroid neoplasia [J]. Annu Rev Pathol, 2018, 13: 141-162.
|
2 |
Lim H, Devesa S, Sosa J, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013 [J]. JAMA, 2017, 317(13): 1338-1348.
|
3 |
Wong R, Farrell S, Grossmann M. Thyroid nodules: diagnosis and management [J]. Med J Aust, 2018, 209(2): 92-98.
|
4 |
Haugen B. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? [J]. Cancer, 2017, 123(3): 372-381.
|
5 |
Chung S, Choi Y, Lee S, et al. Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma [J]. Thyroid, 2021, 31(3): 452-458.
|
6 |
Nakamura T, Miyauchi A, Ito Y, et al. Quality of life in patients with low-risk papillary thyroid microcarcinoma: active surveillance versus immediate surgery [J]. Endocr Pract, 2020, 26(12): 1451-1457.
|
7 |
Wang K, Xu J, Li S, et al. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma [J]. Cancer Med, 2019, 8(16): 6977-6985.
|
8 |
Lee K, Cho Y, Kim S, et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size [J]. World J Surg, 2011, 35(2): 318-323.
|
9 |
Zhang L, Wei W, Ji Q, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients [J]. J Clin Endocrinol Metab, 2012, 97(4): 1250-1257.
|
10 |
Bernet V. Approach to the patient with incidental papillary microcarcinoma [J]. J Clin Endocrinol Metab, 2010, 95(8): 3586-3592.
|
11 |
Sun J, Jiang Q, Wang X, et al. Nomogram for preoperative estimation of cervical lymph node metastasis risk in papillary thyroid microcarcinoma [J]. Front Endocrinol (Lausanne), 2021, 12: 613974.
|
12 |
Hu Y, Cao X, Zhou Y, et al. Management of sonographically suspicious thyroid nodules 1 cm or smaller and candidacy for active surveillance: experience of a tertiary center in China [J]. Endocr Pract, 2021: S1530-891X(21)00048-3. Online ahead of print.
|
13 |
Trimboli P, Castellana M, Virili C, et al. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference [J]. Radiol Med, 2020, 125(4): 406-415.
|
14 |
Li X, Gao F, Li F, et al. Qualitative analysis of contrast-enhanced ultrasound in the diagnosis of small, TR3-5 benign and malignant thyroid nodules measuring ≤1 cm [J]. Br J Radiol, 2020, 93(1111): 20190923.
|
15 |
Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules [J]. Eur J Endocrinol, 1998, 138(1): 41-46.
|
16 |
Siegel R, Miller K, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30.
|
17 |
Zou Q, Ma S, Zhou X. Association of sonographic features and clinicopathologic factors of papillary thyroid microcarcinoma for prevalence of lymph node metastasis: a retrospective analysis [J]. Arch Endocrinol Metab, 2020: 2359-3997000000297. Online ahead of print.
|
18 |
Medas F, Canu G, Cappellacci F, et al. Predictive factors of lymph node metastasis in patients with papillary microcarcinoma of the thyroid: retrospective analysis on 293 cases [J]. Front Endocrinol (Lausanne), 2020, 11: 551.
|
19 |
Zhao L, Sun X, Luo Y, et al. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas [J]. Ann Diagn Pathol, 2020, 49: 151647.
|
20 |
Wang Y, Nie F, Wang G, et al. Value of combining clinical factors, conventional ultrasound, and contrast-enhanced ultrasound features in preoperative prediction of central lymph node metastases of different sized papillary thyroid carcinomas [J]. Cancer Manag Res, 2021, 13: 3403-3415.
|
21 |
叶添添, 夏宇, 姜玉新, 等. 甲状腺微小乳头状癌原发病变超声特点与颈部大量淋巴结转移的相关性 [J/CD]. 中华医学超声杂志(电子版), 2017, 14(10): 760-765.
|
22 |
Dong Y, Wang D, Luo Y, et al. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma [J]. Oncol Lett, 2021, 21(3): 188.
|
23 |
Zhou B, Wei L, Qin J. Does multifocal papillary thyroid microcarcinoma with a total tumor diameter>1 cm indicate poor biological behavior? The evidence is insufficient [J]. Endocr Pract, 2021, 27(2): 131-136.
|
24 |
Yan T, Qiu W, Song J, et al. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: a propensity score matching analysis [J]. Clin Endocrinol (Oxf), 2021, 95: 209-216.
|
25 |
Hong Y, Yan C, Mo G, et al. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases [J]. Sci Rep, 2015, 5(1): 7748.
|
26 |
章美武, 吕淑懿, 范晓翔, 等. 甲状腺微小乳头状癌颈部淋巴结转移的相关危险因素 [J/OL]. 中华医学超声杂志(电子版), 2021, 18(6): 570-577.
|
27 |
Tao L, Zhou W, Zhan W, et al. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound [J]. J Ultrasound Med, 2020, 39(10): 2071-2080.
|
28 |
樊秋兰, 陈霰, 于春洋, 等. 普通超声及超声造影预测甲状腺微小乳头状癌中央区淋巴结转移的价值 [J]. 中国超声医学杂志, 2016, 32(12): 1060-1062.
|
29 |
樊金芳, 陶玲玲, 詹维伟, 等. 超声造影和弹性成像对甲状腺微小乳头状癌中央组淋巴结转移的价值 [J]. 医学影像学杂志, 2020, 30(9): 1582-1586.
|
30 |
Seifert R, Schäfers M, Heitplatz B, et al. Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases [J]. J Nucl Med, 2021: jnumed.121.261898. Online ahead of print.
|